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Inflammasomes promote immunity to microbial path-
ogens by regulating the function of IL-1-family cyto-
kines such as IL-18 and IL-1b. However, the roles
for inflammasomes during parasitic helminth infec-
tions remain unclear. We demonstrate that mice and
humans infected with gastrointestinal nematodes
display increased IL-18 secretion, which in Trichu-
ris-infected or worm antigen-treated mice and in
macrophages co-cultured with Trichuris antigens or
exosome-like vesicles was dependent on the NLRP3
inflammasome. NLRP3-deficient mice displayed re-
duced pro-inflammatory type 1 cytokine responses
and augmented protective type 2 immunity, which
was reversed by IL-18 administration. NLRP3-depen-
dent suppression of immunity partially required CD4+
cells but was apparent even in Rag1/mice that lack
adaptive immune cells, suggesting that NLRP3 influ-
ences both innate and adaptive immunity. These
data highlight a role for NLRP3 in limiting protective
immunity to helminths, suggesting that targeting the
NLRP3 inflammasome may be an approach for
limiting the disease burden associated with helminth
infections.
INTRODUCTION
The interleukin-1 (IL-1) family of cytokines, in particular, IL-1a,
IL-1b, and IL-18, are important for the initiation and amplification
of innate and adaptive immune responses and resistance
against microbial infections. These cytokines are produced by
innate immune cells such as macrophages, dendritic cells, and
monocytes, as well as non-hematopoietic cells such as epithelial
or endothelial cells (Sims and Smith, 2010). Because of their
potent and diverse functions, the biological activity of IL-1 family
cytokinesmust be tightly controlled, since dysregulation of theseCell
This is an open access article under the CC BY-Nresponses is associated with the detrimental inflammation asso-
ciatedwith autoimmune diseases (Dinarello, 2011). Regulation of
the activity of many IL-1 cytokines is achieved by inflamma-
somes; multi-protein immune complexes that control the cleav-
age and subsequent activation of immature versions of these cy-
tokines by the intracellular cysteine protease caspase-1 (Netea
et al., 2015).
Inflammasomes play a critical role in immune defense
against small, easily phagocytosed infectious pathogens by
promoting type 1 immune responses via secretion of IL-1b
and IL-18 (McIntire et al., 2009; Strowig et al., 2012; Arbore
et al., 2016). The nod-like receptor (NLR) family, Pyrin Domain
Containing 3 (NLRP3) inflammasome is the most well-charac-
terized inflammasome and is important for immunity to diverse
pathogens such as bacteria (Broz et al., 2010; Muruve et al.,
2008), viruses (Allen et al., 2009; Kamada et al., 2014; Thomas
et al., 2009), protozoan parasites (Gorfu et al., 2014; Silva
et al., 2013), and fungal pathogens (Hise et al., 2009). Other in-
flammasomes, such as NLRP1, AIM2, and NLRC4, are simi-
larly important for anti-microbial defense (Ewald et al., 2014;
Rathinam et al., 2010; Tomalka et al., 2011). Inflammasomes
are also implicated in the immunopathology of a number of in-
flammatory disorders, including diabetes (Lee et al., 2013),
chronic kidney disease and diabetic nephropathy (Vilaysane
et al., 2010), and inflammatory bowel diseases (IBDs) (Villani
et al., 2009).
There is emerging evidence that, in addition to promoting pro-
inflammatory type 1 or type 17 immune responses, inflamma-
somes can directly or indirectly influence type 2 immune re-
sponses. For example, activation of the NLRP3 inflammasome
promotes allergic type 2 inflammation in some murine models
(Besnard et al., 2011; Ritter et al., 2014), and NLRP3 promotes
non-protective type 2 immune responses to infections with the
protozoan parasite Leishmania major (Gurung et al., 2015).
These observations are consistent with a report that NLRP3
can directly promote T-helper type 2 (Th2) cell differentiation
by acting as a transcription factor (Bruchard et al., 2015).
Other studies suggest that NLRP3 may suppress type 2 immune
responses, for example, by inactivation of the alarmin IL-33Reports 23, 1085–1098, April 24, 2018 ª 2018 The Author(s). 1085
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Helminth Infections Promote Cas-
pase 1/11-Dependent IL-18 Expression that
Limits Anti-parasitic Immunity
(A and B) C57BL/6 wild-type (WT) and caspase-1/
11/ mice were infected with Trichuris and
sacrificed at day 14 or day 21 post-infection (p.i.).
Serum IL-18 (A) and IL-1b (B) levels are shown.
(C) Trichuris antigen-specific IgG1 titers at day
21 p.i.
(D) Cecal worm burdens day 21 p.i., pooled from 2
experiments.
(E) Representative images of PAS/Alcian-blue-
stained cecum at day 21 p.i. Scale bar, 50 mm.
(F) Quantification of goblet cell numbers per cecal
crypt unit.
Data are expressed as mean with individual data
points or mean ± SEM and are representative of
4 experiments (n = 4–5/group).
(G and H) Human clinical trial volunteers with ce-
liac disease were infected with 15 Necator ameri-
canus larvae (n = 9) or a mock infection (placebo,
n = 10). Serum IL-18 (G) and IL-1b (H) levels in
individuals pre-infection (week 0) or 20 weeks p.i.
*p < 0.05 compared to WT. #p < 0.05 compared to
day 0 or week 0.(Cayrol and Girard, 2009; Moulin et al., 2007), or indirectly via
promotion of type 1 biased immune responses (Ritter et al.,
2010). Hence, the role of inflammasomes in regulating type 2 im-
mune responses remains incompletely defined.
Type 2 immune responses are associated with protective im-
munity to helminths, while type 1 responses promote chronic
infections and immunopathology, although very little is known
about whether inflammasomes control immunity to parasitic
helminth infection. The blood fluke Schistosoma mansoni se-
cretes proteins that directly activate the NLRP3 inflammasome
and thereby promote IL-1b secretion (Ritter et al., 2010; Fergu-
son et al., 2015), and genetic deficiency of NLRP3 results in
suppressed Th1, Th2, and Th17 immune responses and
reduced liver pathology (Ritter et al., 2010). Similarly, secreted
products from the intestinal nematode Heligmosomoides poly-
gyrus activate the NLRP3 inflammasome in vitro and increase
IL-1b secretion in vitro and in vivo (Zaiss et al., 2013); however,
the in vivo role for inflammasomes in regulating anti-parasitic
immunity was not determined. Hence, while the NLRP3 inflam-
masome is a critical determinant of immunity and immunopa-
thology associated with diverse pathogens, a role for any in-
flammasome complex in controlling type 2 immunity during
infections with large metazoan parasites like gastrointestinal
helminths is unclear.
In the present study, we describe a role for the NLRP3 inflam-
masome in suppressing protective innate and adaptive immune
responses to infection with the gastrointestinal nematode Tri-
churis muris. Trichuris infection resulted in elevated IL-18 secre-
tion in mice, and similar results were seen in human subjects
experimentally infected with gastrointestinal nematodes. In vivo1086 Cell Reports 23, 1085–1098, April 24, 2018and in vitromurine studies revealed that proteins and exosome-
like extracellular vesicles secreted by Trichuris enhance NLRP3-
dependent IL-18 and IL-1b secretion, in combination with micro-
bial signals such as lipopolysaccharide (LPS). Targeted ablation
of NLRP3 caused reduced type 1 cytokine responses, increased
type 2 responses, accelerated worm expulsion, and lessened in-
testinal immunopathology, which was reversed by rIL-18 admin-
istration. While the presence of CD4+ cells was important for the
ability of NLRP3 to influence anti-parasitic immunity, NLRP3
could suppress protective immunity to Trichuris even in the
absence of a fully functional adaptive immune system, high-
lighting a complex mechanism by which the NLRP3 inflamma-
some regulates inflammation and immunity to parasitic helminth
infections.
RESULTS
Helminth Infections Promote Caspase-1-Dependent
IL-18 Expression that Limits Anti-parasitic Immunity
To investigate whether helminth infection was associated with
inflammasome activation, wild-type (WT) C57BL/6 mice were in-
fected with T. muris and IL-18 and IL-1b levels were quantified in
the serum at different time points post-infection (p.i.). Caspase-
1/caspase-11 double-deficient mice were included as a control
due to their impaired ability to be activated by most inflamma-
some complexes (Schroder and Tschopp, 2010). Trichuris infec-
tion in WT mice caused significant elevations in serum IL-18
levels at day 21 p.i. (Figure 1A), while IL-1b levels were not signif-
icantly increased at any time point (Figure 1B). Caspase-1/11-
deficient mice had significantly reduced serum IL-18 and IL-1b
levels compared with WT mice, suggesting that Trichuris elicits
caspase-1/11 dependent IL-18 expression (Figures 1A and
1B). Following infection, caspase-1/11-deficient mice had
increased Trichuris antigen (Ag)-specific serum immunoglobulin
G1 (IgG1) titers (Figure 1C) and significantly reduced worm
burdens at day 21 p.i compared with WT mice (Figure 1D), sug-
gesting improved anti-parasitic immunity. Consistent with an
increased anti-parasitic response, caspase-1/11-deficient mice
displayed significantly increased numbers of goblet cells in the
cecum compared with infected WT mice (Figures 1E and 1F).
Together, these data suggest that caspase-1/11-dependent
inflammasome activation suppresses immunity to Trichuris
infection.
We next aimed to determine whether gastrointestinal nema-
tode infection of humans was also associated with inflamma-
some activation. Nineteen otherwise healthy subjects with celiac
disease (on a gluten-free diet) from a non-helminth endemic area
(Brisbane, Australia) were either infected with 15 Necator amer-
icanus (human hookworm) infective third-stage larvae (L3, n = 9)
or were treated with a placebo (chili pepper solution, n = 10) and
serum was collected at week 0 (day of treatment) and week 20
post-inoculation. Interestingly, helminth-infected humans, but
not placebo-treated humans, displayed significant increases in
serum IL-18 levels at week 20 p.i. (Figure 1G). IL-1b levels
were typically below the level of detection of the assay and not
impacted by helminth or placebo treatment (Figure 1H). These
data suggest that gastrointestinal helminth infections in humans
are also associated with inflammasome activation, specifically
resulting in elevated IL-18 production.
Trichuris and Its Secreted Factors Promote
NLRP3-Dependent In Vivo and In Vitro Secretion of IL-18
and IL-1b
Inflammasomes are multi-protein complexes that contain mem-
bers of the NLR family of proteins (i.e., NLRP3, NLRP1, NLRC4)
or non-NLR proteins such as AIM2, which give the various in-
flammasomes their distinct properties and effector functions
(Davis et al., 2011). Since the ligands for NLRP1, NLRC4, and
AIM2 have been defined and are not likely to be contained within
Trichuris (other than DNA), the well-characterized NLRP3 inflam-
masome was a likely mediator. Hence, we examined the poten-
tial role for the NLRP3 inflammasome in Trichuris-mediated stim-
ulation of IL-18 and IL-1b secretion.WT andNLRP3– /– micewere
infected with T. muris and serum IL-18 and IL-1b levels were
measured at day 21 p.i. While WT mice exhibited significant in-
creases in serum IL-18 and a trend toward increased IL-1b levels
compared to naive mice, NLRP3– /– mice displayed significantly
reduced levels of these cytokines (Figure 2A), suggesting that
NLRP3 is important for in vivo IL-18 and IL-1b secretion. Previ-
ous studies have demonstrated that factors excreted and
secreted by worms can activate inflammasomes in vitro (Ritter
et al., 2010; Zaiss et al., 2013; Ferguson et al., 2015). To examine
whether products released by Trichuris similarly activate inflam-
masomes, we purified excretory/secretory (ES) products from
Trichuris adult worms and injected WT mice or NLRP3– /– mice
intraperitoneally (i.p.) daily for 6 days and measured circulating
IL-18 and IL-1b levels at days 2 and 6. Injection of WT mice
with ES products resulted in significantly increased levels ofserum IL-18 and IL-1b at 2 days post-injection, with even higher
levels at day 6 post-injection (Figure 2B). In contrast, NLRP3/
mice exhibited no increases in these cytokines following ES in-
jection, suggesting that factors excreted or secreted by Trichuris
may promote in vivo NLRP3 inflammasome-mediated IL-18 and
IL-1b secretion.
We next adopted in vitro experiments to determine which cell
type may be responsive to Trichuris ES, and whether ES prod-
ucts are sufficient for NLRP3-dependent IL-18 and IL-1b secre-
tion. Macrophages are key cells responsible for inflammasome
activation in response to pathogens (Sims and Smith, 2010),
including helminths (Ferguson et al., 2015). Therefore, we
generated bone-marrow-derived macrophages from WT mice
and cultured them in the presence and absence of Trichuris
ES products, known inflammasome activators (LPS and niger-
icin toxin) or culture media alone. Culturing macrophages from
WT mice with ES, LPS, or nigericin alone did not cause signif-
icant increases in IL-18 or IL-1b secretion compared to media
control (Figure 2C). As expected, LPS and nigericin stimulation
did significantly increase IL-18 or IL-1b secretion compared to
media; however, these levels were increased substantially if
Trichuris ES was also included in the cultures (Figure 2C). We
next aimed to determine whether ES-mediated IL-18 or IL-1b
secretion was dependent on NLRP3 and whether a specific
fraction of Trichuris ES may exert these effects. Parasitic
worm ES products are highly complex mixture of proteins,
lipids, carbohydrates, microRNAs, and small molecules, and
recent studies have highlighted that these can be contained
within extracellular vesicles such as exosomes, which facilitate
host-pathogen interactions and immunomodulation (Eichen-
berger et al., 2018). Similar to results from Figure 2C, ES prod-
ucts or purified exosomes alone or in combination with LPS did
not significantly increase secretion of IL-18 or IL-1b compared
to treatment with media or LPS only (Figure 2D). However, if
WT macrophages were stimulated with ES or exosomes in
the presence of known inflammasome activators (LPS and ni-
gericin), the levels of both IL-18 and IL-1b rose significantly
compared to stimulation with LPS + nigericin alone (Figure 2D).
Critically, this synergistic stimulation of IL-18 or IL-1b secretion
by Trichuris ES products and exosomes was not apparent
when cells from NLRP3– /– mice were used, indicating that
molecules and extracellular vesicles secreted by Trichuris
augment NLRP3-dependent secretion of IL-18 or IL-1b, in con-
cert with microbial signals and toxins.
NLRP3 Limits Protective Type 2 Immunity and Promotes
Interferon-g Responses following Trichuris Infection
Given the critical role for NLRP3 in Trichuris-mediated inflamma-
some activation and IL-18 secretion, we assessed the in vivo role
for NLRP3 in protective immunity to Trichuris infection. Similar to
results seen in caspase 1/11/ mice (Figure 1), NLRP3– /– mice
had significantly increased Trichuris Ag-specific serum IgG1
titers (Figure 3A) and reduced worm burdens at day 14, 21,
and 35 p.i compared to WT mice (Figure 3B). NLRP3– /– mice
also displayed significantly increased frequencies and total
numbers of eosinophils in the mesenteric lymph node (mLN)
compared to WT mice (Figures 3C and 3D), consistent with an
elevated cellular type 2 immune response. Further analysis ofCell Reports 23, 1085–1098, April 24, 2018 1087
Figure 2. Trichuris and Its Secreted Factors
Promote In Vivo and In Vitro NLRP3-Depen-
dent Secretion of IL-18 and IL-1b
(A) WT andNLRP3/mice were infected (INF) with
T. muris, and serum IL-18 and IL-1b levels were
determined at day 21 p.i. (n = 3–5 mice/group). N,
naive mice.
(B) WT and NLRP3/ mice were injected intra-
peritoneally with 50 mg of Trichuris excretory/
secretory (ES) products and were bled immedi-
ately (day 0) or 2 or 6 days post-injection, and
serum levels of IL-18 and IL-1b levels were
determined (n = 3/group).
(C) Bone-marrow-derived macrophages from WT
mice were cultured with combinations of either
25 mg/mL of Trichuris ES, 1 mg/mL LPS, or 20 mM
nigericin. Plus (+) symbols denote inclusion of re-
agent; minus (–) symbol denotes media control.
(D) Bone-marrow-derived macrophages from WT
or NLRP3/ mice were cultured with combina-
tions of 25 mg/mL of Trichuris ES, 25 mg/mL puri-
fied Trichuris adult worm exosomes, 1 mg/mL LPS,
or 20 mM nigericin (n = 4 wells/treatment). IL-18
and IL-1b were measured in supernatants or sera
by ELISA. All results are representative of 3 ex-
periments. *p < 0.05 compared to WT. #p < 0.05
compared to N, DAY 0, or media only control, ^^p <
0.05 compared to LPS + nigericin; ns, not signifi-
cantly different.cellular immune responses at the site of infection (cecum) re-
vealed that Trichuris-infected NLRP3– /– mice displayed elevated
eosinophil frequencies in the cecum compared to WT mice (Fig-
ure S1A). Frequencies of other cell types typically associated
with type 2 immunity such as basophils (Figure S1B), mast cells
(Figure S1C), and macrophages (Figure S1D) were not elevated
in the ceca of infected NLRP3/ mice. The degree of intestinal
immunopathology was significantly decreased in NLRP3/
mice compared to WT mice (Figures 3E and 3F), which corre-
sponded with significantly increased goblet cell responses (Fig-
ures 3G and 3H). One of the most well-studied mechanisms by
which the NLRP3 inflammasome is activated is by engagement
of the P2X7R by extracellular ATP (Riteau et al., 2010). However,
mice deficient in P2X7R do not display the same enhanced im-
munity phenotype as NLRP3/ mice during Trichuris infection,
suggesting that a different pathway to NLRP3 inflammasome
activation may be more important (Figure S2). Together, these
data suggest that the NLRP3 inflammasome inhibits protective
type-2-associated immune responses and promotes immuno-
pathology following Trichuris infections, likely via a P2X7R-inde-
pendent mechanism.1088 Cell Reports 23, 1085–1098, April 24, 2018To investigate the immunological
mechanisms by which NLRP3 controls
immunity to Trichuris infections, we as-
sessed antigen-specific cytokine re-
sponses in the mLN of WT and NLRP3/
mice and cytokine responses in the co-
lon. NLRP3/ mice displayed increased
IL-4 and IL-13 expression by Ag-stimu-
lated mLN cells compared to WT mice(Figure 3I), consistent with an augmented type 2 immune
response in the intestinal draining lymph nodes. This was asso-
ciated with increased levels of IL-13 and thymic stromal lympho-
poietin (TSLP) in the colon tissue (Figure S3A). Levels of the type
2-associated cytokines IL-25 and IL-33 in the colon were not
significantly elevated in infected NLRP3/mice, nor were there
increases in innate lymphoid cell type 2 (ILC2) responses in either
the mLN or colonic lamina propria, since frequencies of CD3–
CD19– CD90+ GATA3+ cells in these tissues were not signifi-
cantly different to those in infected WT mice (Figure S3B).
Together, these data suggest that NLRP3 limits type 2 cytokine
responses to Trichuris infection. The augmented type-2-associ-
ated immune responses observed in NLRP3/ mice was
accompanied by a significant reduction in type 1 cytokine re-
sponses, measured by interferon (IFN)-g expression (Figure 3I).
Given that IFN-g is associated with the development of chronic
infections and suppression of protective type 2 immune re-
sponses to helminths, including Trichuris (Else et al., 1994;
Coomes et al., 2015), we investigated the cellular sources of
IFN-g. While WT mice displayed significant increases in fre-
quencies (Figure 3J) and total numbers (Figure 3K) of CD4+
Figure 3. NLRP3 Limits Protective Type 2 Immunity and Promotes IFN-g Responses following Trichuris Infection
WT and NLRP3– /– mice were infected with T. muris and sacrificed at day 14, day 21, or day 35 p.i. N, naive mice.
(A) Trichuris antigen-specific IgG1 titers at day 21 p.i.
(B) Cecal worm burdens at day 14, day 21, and day 35 p.i. pooled from 2 experiments.
(C) Representative plots displaying Siglec F+ eosinophils frequencies in the mesenteric lymph nodes (mLN) at day 21 p.i.
(D) Total mLN eosinophils.
(E) Representative images of H&E-stained cecum at day 21 p.i. Scale bar, 50 mm.
(F) Blinded scores of cecal pathology, pooled from 4 experiments.
(G) Representative images of PAS/Alcian-blue-stained cecum tissue at day 21 p.i.
(H) Quantification of goblet cell numbers per cecal crypt unit.
(legend continued on next page)
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T cells that express IFN-g, these responses were significantly
diminished in NLRP3/ mice. Similarly, IFN-g responses by
non-T cells (CD3– cells) were also significantly reduced in the
absence of NLRP3 (Figures 3L and 3M), together suggesting
that NLRP3 promotes innate and adaptive IFN-g responses
following helminth infection, potentially representing a mecha-
nism by which inflammasomes limit protective type 2 immunity
to helminths.
Therapeutic NLRP3 Inhibition Suppresses Type 1
Immune Responses and Promotes Resistance to
Trichuris Infection
To confirm the role for NLRP3 in regulating immunity to Trichuris
infection, and to avoid potential impacts of developmental abnor-
malities in gene knockout mice, we next targeted the NLRP3 in-
flammasome therapeutically with a selective chemical inhibitor
MCC950 (Coll et al., 2015). C57BL/6 WT mice were i.p. treated
daily with either PBS vehicle control or 20 mg/kg/day of
MCC950 starting on the initial day ofTrichuris infection. Treatment
with MCC950 lowered serum IL-18 and IL-1b levels in Trichuris-
infected mice, but these reductions were not statistically signifi-
cant (Figures 4A and 4B). MCC950 treatment significantly
increased serum titers of Trichuris Ag-specific IgG1 (Figure 4C),
significantly lowered worm burdens at day 21 p.i. (Figure 4D)
and resulted in a non-significant trend toward increased mLN
eosinophil numbers compared to the PBS control-treated mice
(Figure 4E), consistent with enhanced anti-parasitic responses.
Trichuris-infected mice treated with MCC950 displayed evidence
of decreased intestinal inflammation compared to PBS control
mice; however, blinded pathology scores were not significantly
reduced (Figures 4F and 4G). MCC950 treatment resulted in
elevated Trichuris Ag-specific type 2 cytokine responses in the
mLN and concurrent significant reductions in IFN-g responses
(Figure 4H). Analysis of the cellular sources of IFN-g revealed
that IFN-g responses by CD4+ CD3+ T cells and non-T cells
(CD3– cells) were both significantly reduced by MCC950 treat-
ment (Figures 4I and 4J). Together, these data suggest that tar-
geting the NLRP3 inflammasome therapeutically with a chemical
inhibitor has a similar phenotypic effect to genetic NLRP3
deficiency.
Exogenous Delivery of rIL-18 Reverses the Enhanced
Anti-parasitic Immunity of NLRP3-Deficient Mice
Activation of the NLRP3 inflammasome can have multiple down-
stream effects, including the release of mature IL-18, IL-1b, and
regulation of IL-33 secretion (Strowig et al., 2012). Data thus far
have indicated that Trichuris infection increases IL-18 expres-
sion, and ablation of NLRP3 diminishes this response, suggest-
ing that NLRP3 may control immunity or susceptibility to this
parasite by regulating IL-18. To more precisely define the molec-
ular mechanism of how NLRP3 controls immunity to Trichuris,(I) Trichuris antigen-specific IL-4, IL-13, and IFN-g production by restimulated m
(J) Frequencies of CD3+ CD4+ IFN-g+ cells in the mLN following ex vivo stimulati
(K) Total mLN CD4+ IFN-g+ cells.
(L) Frequencies of CD3– IFN-g+ cells in the mLN.
(M) Total mLN CD3 IFN-g+ cells. Data are expressed as mean with individual data
group. *p < 0.05 compared to WT; ns, not significantly different.
1090 Cell Reports 23, 1085–1098, April 24, 2018we examined whether delivery of exogenous IL-18 to NLRP3-
deficient mice could reverse the robust immunity of NLRP3-defi-
cient mice. NLRP3– /– mice were either treated every 3 days with
PBS vehicle or recombinant murine IL-18 (200 ng/mouse i.p.)
from days 7–19 post-Trichuris infection. C57BL/6 WT mice
were included as a control and received PBS only. Results
demonstrated that, as expected, the levels of IL-18 in the serum
were increased in NLRP3– /– mice treated with rIL-18 (Figure 5A).
Furthermore, while NLRP3– /– mice treated with PBS exhibited a
trend toward increases in Trichuris Ag-specific serum IgG1 titers
(Figure 5B) and significantly increased eosinophil numbers in the
mLN (Figure 5C), rIL-18 treatment of NLRP3/mice normalized
these responses to WT + PBS levels (Figures 5B and 5C). Simi-
larly, rIL-18 treatment of NLRP3/ mice resulted in significantly
higher worm burdens (Figure 5D) and increased CD4+ IFN-g re-
sponses (Figure 5E) and a trend toward increasedCD3– IFN-g re-
sponses (Figure 5F) compared to NLRP3/ mice treated with
PBS. Last, treatment of NLRP3/ mice with rIL-18 led to
increased inflammation in the cecum (Figure 5G) and a signifi-
cant increase in pathology score compared to PBS-treated
mice (Figure 5H). Together, these data suggest that NLRP3
may limit immunity to Trichuris by enhancing IL-18 production,
which promotes type 1 cytokine responses and resultant immu-
nopathology associated with Trichuris infections.
NLRP3 Partially Requires CD4+ T Cells to Limit
Protective Immunity to T. muris Infection
Inflammasomes are critical mediators of innate immunity to in-
fections (Strowig et al., 2012); however, they can also influence
the development of adaptive immunity via regulation of T cell
responses (Ciraci et al., 2012). Further, CD4+ T cells can also
express NLRP3 inflammasomes, which can promote Th1 cell dif-
ferentiation (Arbore et al., 2016). Immunity to Trichuris is depen-
dent on the generation of adaptive CD4+ T cell responses,
hence, to assess whether NLRP3-dependent regulation of im-
munity to Trichuris is dependent on CD4+ T cells, WT or
NLRP3/ mice were treated every 3 days with either 0.5 mg
of a neutralizing anti-CD4 mAb or a control rat IgG following Tri-
churis infection. As expected, treatment with anti-CD4 mAb was
able to effectively deplete CD3+ CD4+ cells in infected mice (Fig-
ure 6A). While NLRP3/ mice treated with control Ig exhibited
characteristic significant increases in total mLN eosinophils
compared to WT mice (Figure 6B), these responses were signif-
icantly diminished when CD4+ cells were ablated. Anti-CD4mAb
treatment caused a significant increase in worm burdens in
NLRP3/ mice at day 21 p.i. compared to control IgG-treated
mice (Figure 6C), which corresponded with significantly
increased cecal pathology (Figures 6D and 6F) and significantly
reduced presence of goblet cells (Figures 6E and 6G). Together,
these data suggest that CD4+ cells are partially required for the
ability of NLRP3 to suppress immunity to Trichuris infection.LN cells.
on.
points, or mean ± SEM, and are representative of 7 experiments where n = 4–5/
Figure 4. Therapeutic NLRP3 Inhibition Suppresses Type 1 Immune Responses and Promotes Resistance to Trichuris Infection
(A–C) C57BL/6 WT mice were treated intraperitoneally (i.p.) daily with either PBS or 20 mg/kg/day of MCC950 following T. muris infection (INF) and sacrificed at
day 21 p.i. Serum IL-18 (A) and IL-1b (B) levels and Trichuris antigen-specific serum IgG1 titers (C) are shown. N, naive mice.
(D) Worm burdens, pooled from 2 experiments.
(E) Total mesenteric lymph node (mLN) eosinophils.
(F) Representative images of H&E-stained cecum tissue. Scale bar, 50 mm.
(G) Blinded scores of cecal pathology.
(H) Trichuris antigen-specific IL-4, IL-13, and IFN-g secretion by restimulated mLN cells.
(I) Total mLN CD4+ IFN-g+ cells.
(J) Total mLNCD3– IFN-g+ cells. Data are expressed asmean with individual data points or mean ± SEM and are representative of 4 experiments, n = 4–5 infected
or 1–2 naive mice/group. *p < 0.05 compared to PBS control; ns, not significantly different.NLRP3 Can Regulate Immunity to Trichuris Independent
of the Adaptive Immune System
To further define the cellular mechanisms of NLRP3-dependent
regulation of immunity to infection, we aimed to assess whether
NLRP3 could influence innate immunity to Trichuris. C57BL/6
Rag1/ mice (which do not possess a functional adaptive
immune system) were infected with Trichuris treated daily
with either PBS or 20 mg/kg/day i.p. of MCC950. C57BL/6
WT mice were included as a control for assessment of wormburdens. Critically, MCC950 treatment was able to significantly
reduce worm burdens in Rag1/ mice at day 21 p.i. compared
to PBS-treated mice (Figure 7A), which corresponded with
significantly increased eosinophil numbers in the mLN (Fig-
ure 7B). Analysis of cytokine responses in the mLN revealed
that while Rag1– /– mice treated with PBS displayed increased
IFN-g responses within cells that express CD90 following infec-
tion, mice that received the MCC950 had a reduced IFN-g
response in these cells (Figure 7C). Further analysis of thisCell Reports 23, 1085–1098, April 24, 2018 1091
Figure 5. Exogenous Delivery of rIL-18 Reverses the Enhanced Anti-parasitic Immunity of NLRP3-Deficient Mice
NLRP3– /– mice were either daily treated with PBS vehicle or recombinant murine IL-18 (200 ng/mouse i.p.) from days 7–19 post-Trichuris infection (INF) and were
sacrificed at day 21 p.i. WT control mice received PBS only.
(A) Serum IL-18 levels.
(B) Trichuris antigen-specific serum IgG1 titers.
(C) Total mLN eosinophils. N, naive mice.
(D) Worm burdens.
(E) Total CD3+ CD4+ IFN-g+ cells in the mesenteric lymph node (mLN).
(F) Total mLN CD3– IFN-g+ cells.
(G) Representative images of H&E-stained cecum tissue from infected mice. Scale bar, 50 mm.
(H) Blinded scores of cecal pathology. Data are expressed as mean with individual data points or mean ± SEM and are representative of 3 experiments, n = 4–6
mice/group. *p < 0.05; ns, not significantly different.cell population demonstrated that IFN-g-expressing CD90+
cells following Trichuris infection co-expressed the ILC markers
Sca-1 and CD127 as well as T-bet (Figure 7D), a phenotype
consistent with ILC type 1 cells (ILC1). Histological analyses
demonstrated that, while MCC950 treatment did not result in
significant reductions in immunopathology in the cecum (Fig-
ures 7E and 7G), there were significant increases in goblet
cell responses (Figures 7F and 7H). These data suggest that1092 Cell Reports 23, 1085–1098, April 24, 2018the NLRP3 inflammasome can influence innate immunity to Tri-
churis infection, potentially acting via regulation of the function
of innate cells such as ILC1s, and, when taken into consider-
ation with results that CD4+ T cells are also important for
NLRP3-dependent immune regulation (Figure 6), imply that
the NLRP3 inflammasome can influence elements of both the
innate and adaptive immune system to limit protective immu-
nity to helminths.
Figure 6. NLRP3 Partially Requires CD4+ T Cells to Limit Protective Immunity to T. muris Infection
WT or NLRP3/ mice were treated every 3 days with either 0.5 mg of a neutralizing anti-CD4 mAb or a control rat IgG following T. muris infection and were
sacrificed at day 21 p.i.
(A) Representative plots demonstrating successful depletion of CD3+ CD4+ cells in mesenteric lymph nodes (mLN) of infectedmice following anti-CD4 treatment.
(B) Total mLN eosinophils.
(C) Worm burdens.
(D) Representative images of H&E-stained cecum tissue.
(E) Representative images of PAS/Alcian-blue-stained cecum tissue.
(F) Blinded scores of cecal pathology.
(G) Blinded quantification of goblet cell numbers per cecal crypt unit. Scale bar, 50 mm. Data are expressed as mean with individual data points and are
representative of 2 experiments, n = 4–5 mice/group. *p < 0.05; ns, not significantly different.DISCUSSION
Parasitic helminth infections are among the most common and
debilitating causes of chronic disease in humans, infecting
over a billion people worldwide. However, there are no vaccines
that can protect humans against infection, owing in part to the
complexity of helminth life cycles, the immune-suppressive ca-
pacity of helminth antigens, and our relative lack of understand-
ing of how protective type 2 immune responses are initiated and
regulated. Inflammasomes are critical regulators of immunity to
pathogens, yet their roles in immunity to parasitic helminths
have been largely unexplored. The present study has identified
a role for the NLRP3 inflammasome in limiting both innate and
adaptive immunity of mice to a gastrointestinal helminth, via
regulation of IL-18 expression. We demonstrate that chronic hel-
minth infections of humans are similarly associated with elevated
IL-18 expression. Critically, targeting this pathway therapeuti-
cally with a chemical inhibitor was able to accelerate type 2 im-
mune-mediated clearance of the parasite, shedding light on howinnate immune receptors control immunity to helminths and
potentially identifying a strategy for limiting the disease burden
in helminth-infected animal or human populations.
NLRP3 has been implicated in promoting type 1 immune-
mediated protection against pathogens and detrimental inflam-
mation in some disease settings (Silva et al., 2013; Thomas
et al., 2009). In addition, recent studies have highlighted that
NLRP3 can have important roles in promoting type 2 immune re-
sponses (Bruchard et al., 2015; Gurung et al., 2015). Our findings
herein are consistent with a role for NLRP3 in promoting non-
protective type 1 immune responses to Trichuris, potentially by
eliciting IL-18 secretion, a cytokine also known as ‘‘IFN-g-
inducing factor’’ (Micallef et al., 1996). IL-18 is a pleiotropic cyto-
kine that can promote either a type 1 or type 2 response, de-
pending on the nature of the cytokine milieu, infectious stimuli,
and genetic background of the host (Xu et al., 2000). For
instance, IL-18 can induce type 1 immune responses and resis-
tance to one species of the Leishmania parasite (Li et al., 2004)
but induces non-protective type 2 responses to another speciesCell Reports 23, 1085–1098, April 24, 2018 1093
Figure 7. NLRP3 Can Regulate Immunity to T. muris Independent of
the Adaptive Immune System
C57BL/6 Rag1– /– mice were treated daily with either PBS or 20 mg/kg/day i.p.
of the NLRP3 inhibitor, MCC950 following Trichuris infection and were sacri-
ficed at day 21 p.i. C57BL/6WTmice received PBS only and were only used as
a control for worm burden.
(A) Worm burdens.
(B) Total mLN eosinophils.
(C) Frequencies of CD90+ IFN-g+ cells in the mLN.
(D) IFN-g-expressing CD90+ cells (shaded histograms) were gated and
analyzed for co-expression of ILC markers Sca-1, CD127, and T-bet. Clear
histograms represent gated CD90– cells from the same sample.
(E) Representative images of H&E-stained cecum tissue.
(F) Representative images of PAS/Alcian-blue-stained cecum tissue.
(G) Blinded scores of cecal pathology.
(H) Blinded quantification of goblet cell numbers per cecal crypt unit. Scale
bar, 50 mm. Data are expressed as mean with individual data points and are
representative of 3 experiments, n = 5–6 mice/group. *p < 0.05 compared to
NLRP3–/– + rat Ig. ns, not significantly different.
1094 Cell Reports 23, 1085–1098, April 24, 2018(Bryson et al., 2008). Previous studies have demonstrated that
IL-18 is a critical regulator of immunity to Trichuris, with differ-
ences in the relative role depending on the inflammatory context.
While one report highlights how IL-18 promotes type 2 re-
sponses when IFN-g is absent (Liu et al., 2006), another report
implicates IL-18 in suppressing type 2 cytokine responses to Tri-
churis (Helmby et al., 2001), which is more consistent with our
findings in NLRP3/ mice. Hence it is likely that, in the context
of the present study, lowered IL-18 expression in the absence of
NLRP3 may contribute to the elevated type 2 responses and
diminished type 1 responses following Trichuris infection. How-
ever, it remains unclear whether elevations in type 2 immunity
were a consequence, or a cause, of reductions in Th1 cell or
ILC1 responses observed in NLRP3/ mice (i.e., cross-regula-
tion of type 1 versus type 2 responses), or whether this was a
direct effect of IL-18 or other factors.
Our data are supportive for a central role for NLRP3-depen-
dent IL-18 in regulating immunity and inflammation following Tri-
churis infection, but we have also demonstrated that IL-1b levels
are similarly regulated by NLRP3, MCC950, and caspase-1/11,
raising the question as to the role for IL-1b in this system. While
IL-1b can have a role in suppressing protective immunity to other
helminth species (Zaiss et al., 2013), this contrasts with what is
observed during Trichuris infections, where IL-1/IL-1R interac-
tions promote type 2 immunity (Helmby andGrencis, 2004; Hum-
phreys and Grencis, 2009). IL-1b also has an emerging role in
stimulating ILC2 responses (Ohne et al., 2016) suggesting that,
at least in the context of Trichuris infection, defective IL-1b pro-
duction in NLRP3/micewould be unlikely to be responsible for
the increased type 2 immune responses we observed in the pre-
sent study.
The NLRP3 inflammasome can be activated by a wide variety
of stimuli, ranging from pathogen-associated molecular pat-
terns, danger signals (ATP, ADP, DNA), toxins, and crystals
(Schroder and Tschopp, 2010). We found that Trichuris adult
worms release factors that can support NLRP3-dependent
IL-18 and IL-1b secretion in vivo and in cultured macrophages.
Interestingly, worm secreted factors do not appear to induce
NLRP3-dependent IL-1b and IL-18 secretion alone, since signals
from known inflammasome activators (e.g., LPS and nigericin)
were also required. It is therefore unclear whether worm-derived
molecules are operating as a ‘‘first signal’’ to promote pro-IL-1b/
pro-IL-18 generation or as a ‘‘second signal’’ to activate the
NLRP3 inflammasome and promote cytokine maturation and
release, or both. We also cannot definitively say that Trichuris
and its secretions definitively elicit in vivo IL-18 secretion, since
it remains possible that IL-18 secretion is diminished in the
absence of NLRP3 due to an inability to respond to the micro-
biota. Regardless, our results are consistent with the premise
that worm-derived factors may be able to augment NLRP3 acti-
vation, provided that signals from commensal microbes are also
present.
While our study has not pinpointed the precise worm-derived
molecule(s) responsible for enhancing NLRP3-dependent IL-1b
and IL-18 secretion, as has been demonstrated for schisto-
somes (Ritter et al., 2010), we found that purified exosome-like
extracellular vesicles released from the worm can mediate
these effects. Helminth-derived exosomes have been recently
implicated in immune modulation (Buck et al., 2014) and patho-
genesis (Chaiyadet et al., 2015) by parasitic helminths. T. muris
exosomes contain hundreds of proteins, micro-RNAs, and
mRNAs that are postulated to mediate host-pathogen interac-
tions (Eichenberger et al., 2018), and the present study suggests
that some of these factors may regulate activation of inflamma-
somes by host cells such as macrophages. Given that activation
of this pathway is associated with greater parasite persistence in
the intestine, it is possible that parasites such as Trichuris may
have evolved strategies to selectively target inflammasomes to
regulate localized inflammation and enhance their survival within
a host (Hewitson et al., 2009). In addition to worm-secreted fac-
tors and signals from commensal microbes, there are likely other
mechanisms by which a worm infection could elicit inflamma-
some activation. For instance, helminth infections can induce
substantial tissue damage during colonization and feeding that
can release danger signals such as ATP, which is a well-
described activator of the NLRP3 inflammasome (Riteau et al.,
2010). However, our finding that the ATP-P2X7R pathway does
not appear to control Trichuris infections in the same way as
NLRP3 suggests that other activation pathways are likely to
play more substantial roles. Other danger signals such as ADP
can also activate inflammasomes (Baron et al., 2015) and can
promote immunity to helminths by interacting with A2B recep-
tors (Patel et al., 2014).
While inflammasomes are critical regulators of early innate re-
sponses to infection, by permitting rapid maturation and release
of inflammatory cytokines, there is substantial evidence that in-
flammasomes are involved in shaping adaptive immunity (Ciraci
et al., 2012). Our results are consistent with multiple roles for the
NLRP3 inflammasome in controlling immunity to gastrointestinal
helminths. NLRP3/ mice display enhanced parasite antigen-
specific humoral and type 2 cytokine responses and the pres-
ence of CD4+ T cells is important for the optimal ability of
NLRP3 to suppress protective immunity to Trichuris, demon-
strating that NLRP3 regulates adaptive immunity. Our results
could not distinguish a potential role for CD4+ T cell-intrinsic
NLRP3 activation in regulating immunity to Trichuris, as has
been shown in other models of infection and inflammation (Ar-
bore et al., 2016); hence it remains possible that CD4 cells could
either be an upstream mediator (inflammasome activation) or
downstream mediator (Th2-driven inflammation) of immunity.
However, the fact that NLRP3 could suppress immunity to Tri-
churis in the absence of functional T cells and B cells (in Rag1/
mice) highlights the importance of NLRP3 in innate immunity.
The precisemechanisms bywhich NLRP3 suppresses the innate
response to Trichuriswas not defined, but the selective elevation
in eosinophil numbers in lymph nodes and intestinal tissues,
increased goblet cell responses, and the modulation of ILC1
function that arose following NLRP3 inhibition suggests that
there may be multiple mechanisms involved. Previous reports
have shown that NLRP3-dependent IL-1b negatively regulates
immunity to different helminth species by suppressing IL-25
and IL-33 (Zaiss et al., 2013), factors that are known to promote
ILC2 responses. However, none of these factors were elevated
in NLRP3/ mice in the present study, suggesting that other
mechanisms may promote type 2 immunity in the context of Tri-
churis infection. Interestingly, TSLP expression was elevated ininfected NLRP3/ mice, and TSLP is strongly associated with
type 2 immune responses and protective immunity to helminths,
including Trichuris (Taylor et al., 2009), via associations with a
range of accessory cells including dendritic cells, basophils,
ILCs, and mast cells. It is also possible that the absence of
NLRP3-dependent cell death or pyroptosis in NLRP3-deficient
mice may result in increased survival of innate immune cells
(McIntire et al., 2009), which could provide increased immunity
to parasitic helminth infection. Further, NLRP3 inhibition may in-
fluence the functions of non-hematopoietic cells in the intestine
that promote worm expulsion, including epithelial cell turnover,
goblet cell expansion, and mucus production and smooth mus-
cle hyper-contractility.
Our observations that humans infected with a gastrointestinal
nematode exhibit elevated serum IL-18 levels are consistent with
activation of inflammasomes. Hence, it is conceivable that tar-
geting the NLRP3 pathway in helminth-infected humans using
MCC950 may be a rational approach for boosting type 2 immu-
nity to helminths, lowering worm burdens and limiting the health
problems these infections cause in the developing world. How-
ever, people living in helminth endemic regions are often
exposed to co-infections with bacterial, viral, and parasitic path-
ogens such as tuberculosis, HIV, and malaria, and previous
studies have demonstrated a protective role for NLRP3 in these
infection models (Dorhoi et al., 2012; Shio et al., 2009). Hence,
caution would be warranted to prevent such therapeutic strate-
gies from having unwanted effects of reduced ability to fight
other infections. Nevertheless, administering therapies that
enhance a patient’s natural ability to mount protective type 2 im-
mune responses would have benefits over the use of anthel-
mintic drugs alone; for example, NLRP3 inhibition could promote
the development of more robust parasite-specific memory Th2
cells and IgG1 responses that could protect an individual from
reinfection. In conclusion, we have provided information on
how the NLRP3 inflammasome regulates immunity and inflam-
mation in helminth infections. Further work is necessary to define
the role of this pathway in immunity to other helminth species
and the roles for other inflammasomes (e.g., NLRP1, AIM2,
NLRP6, NLRC4) in regulation of type 2 immune responses.EXPERIMENTAL PROCEDURES
Mice and Treatments
Caspase-1/11 double-deficient, NLRP3-deficient, P2X7R-deficient, and Rag-
1-deficient mice, all on C57BL/6 genetic background, and C57BL/6 WT
mice were bred and maintained at James Cook University (JCU) Cairns
Campus. Male and female mice between 6 and 10 weeks of age were used.
Experimental protocols were approved by the JCU Animal Ethics Committee
(approval A2213). Mice were injected intraperitoneally (i.p.) with 50 mg of Tri-
churis muris adult worm ES antigens in PBS. Mice were i.p. treated with
20 mg/kg/day of MCC950 (Coll et al., 2015) or PBS vehicle, daily starting on
day 0 of Trichuris infection. Mice were treated with neutralizing antibodies
against CD4 (GK1.5, Bioxcell, 0.5 mg/mouse) starting on day 0 and continuing
every 3 days. Recombinant murine IL-18 (R&D Systems) or PBS vehicle were
injected i.p. at a dose of 200 ng/mouse daily from days 7–19 post-Trichuris
infection.
Human Ethics and Experimental Procedures
The design and clinical results of the placebo-controlled clinical trial using
N. americanus to treat celiac disease have been described elsewhereCell Reports 23, 1085–1098, April 24, 2018 1095
(Daveson et al., 2011). The trial was registered at https://clinicaltrials.gov/ as
NCT00671138. Briefly, otherwise healthy people with HLA-DQ2+ celiac dis-
ease on a gluten-free diet were recruited, randomized into two groups, and
either infected percutaneously with 15 infective larvae of N. americanus or
given placebo treatment with topical chili pepper solution. Bloodwas collected
by venepuncture and serum was collected and stored at 80C.
Parasitological Techniques
T. muris was maintained in genetically susceptible mouse strains and T. muris
ES antigens were obtained as described previously (Artis et al., 1999). Mice
were infected by oral gavage with approximately 200 embryonated T. muris
eggs. Trichuris-specific serum IgG1 titers were assayed by ELISA on plates
with coated with T. muris antigen (5 mg/mL). Maintenance of the life cycle of
Necator americanus and experimental infections of human subjects were per-
formed as described previously (Daveson et al., 2011).
Bone Marrow Macrophage Assays
Bone marrow was isolated from hind legs of C57BL/6 or NLRP3/ mice by
flushing bones with DMEM, and cells were cultured at 1 3 106 cells/mL in
DMEM supplemented with 10% fetal bovine serum (FBS), 5% horse serum
(Invitrogen), 2 mM L-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, and
10 ng/mL macrophage colony stimulating factor (M-CSF). On day 6, macro-
phages were harvested and plated overnight at a concentration of 2 3 105
cells/mL. The following day, cells were treated with media alone or LPS
(1 mg/mL) for 4 hr, 20 mM nigericin for 2 hr and 25 mg/mL of Trichuris adult
worm ES products or 25 mg/mL worm exosomes for 6 hr, and cell-free super-
natants were stored at 80C.
Mouse Tissue Collection, Processing, and Pathology Scoring
Blood was collected by cardiac puncture for terminal procedures, or subman-
dibular bleeding for non-terminal procedures, and serumwas stored at80C.
Single-cell suspensions of mLN or cecal patch tissue were prepared by pass-
ing through 70-mm nylon mesh filters. Colonic lamina propria lymphocytes
(LPLs) were isolated as described previously (Zaph et al., 2007). For colon tis-
sue homogenates, 1 cm of tissue was homogenized mechanically in 0.5 mL of
PBS using a TissueLyzer (QIAGEN), and supernatants were stored at 80C.
Cecal tissue was fixed in 4% paraformaldehyde and embedded in paraffin,
and 5-mM sections were stained with H&E or periodic acid-Schiff (PAS)/Alcian
blue stains. Scoring of pathology was performed from H&E-stained slides by
an individual blinded to the experimental group. Tissue sections were scored
on a scale of 0–5 for the following parameters: (1) epithelial pathology (crypt
elongation, hyperplasia, erosion), (2) mural inflammation, and (3) edema for a
maximal score of 15. Goblet cell responses were assessed by counting
PAS-positive cell number per crypt unit, with a minimum of 20 crypt units as-
sessed for each tissue sample. For determination of worm burdens, ceca were
collected, and worms were counted using a dissecting microscope.
Statistical Analyses
Statistical analyses for murine in vitro and in vivo studies were performed using
unpaired Mann-Whitney U tests. Human cytokine data were compared using
paired Mann-Whitney U tests. In vivo mouse experiments included n = 1–3
naive control mice and a minimum of n = 4–6 infected mice and were
repeated at least twice to demonstrate reproducibility. Results are expressed
as mean ± SEM or as individual data points and the differences were consid-
ered significant at a p value of <0.05.
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